Cargando…

Aspirin for Prevention of Cardiovascular Disease

We used data from the 2013 Mississippi Behavioral Risk Factor Surveillance System to examine aspirin use for the prevention of primary and secondary cardiovascular disease (CVD), based on the 2009 US Preventive Services Task Force (USPSTF) guidelines, among Mississippi men (aged 45–79 y) and women (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendy, Vincent L., Vargas, Rodolfo, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2017
Materias:	Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590489/ https://www.ncbi.nlm.nih.gov/pubmed/28880838 http://dx.doi.org/10.5888/pcd14.170171

Ejemplares similares

Cardiovascular Disease Mortality in Mississippi, 2000–2018
por: Mendy, Vincent L., et al.
Publicado: (2022)

Trends in Major Risk Factors for Cardiovascular Disease Among Adults in the Mississippi Delta Region, Mississippi Behavioral Risk Factor Surveillance System, 2001–2010
por: Mendy, Vincent L., et al.
Publicado: (2015)

Food Insecurity and Cardiovascular Disease Risk Factors among Mississippi Adults
por: Mendy, Vincent L., et al.
Publicado: (2018)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Aspirin in the Modern Era of Cardiovascular Disease Prevention
por: Murphy, Ella, et al.
Publicado: (2021)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Decreasing prevalence of no known major risk factors for cardiovascular disease among Mississippi adults, Mississippi Behavioral Risk Factor Surveillance System, 2001 and 2009
por: Mendy, Vincent L., et al.
Publicado: (2016)

Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease
por: Dai, Yuxiang, et al.
Publicado: (2012)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Aspirin use for cardiovascular disease prevention in the uninsured population
por: Liu, Nina, et al.
Publicado: (2020)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Trends in mortality rates by subtypes of heart disease in Mississippi, 1980–2013
por: Mendy, Vincent L., et al.
Publicado: (2017)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
por: Spartalis, Michael, et al.
Publicado: (2023)

Strategy of Prevention of Cardiovascular Disease
por: Kovács, Gábor L., et al.
Publicado: (2003)

Hypertension among Mississippi Workers by Sociodemographic Characteristics and Occupation, Behavioral Risk Factor Surveillance System
por: Mendy, Vincent L., et al.
Publicado: (2020)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Trends in Heart Disease Mortality among Mississippi Adults over Three Decades, 1980-2013
por: Mendy, Vincent L., et al.
Publicado: (2016)

One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project
por: Gansert, Emily, et al.
Publicado: (2023)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015)

Should Aspirin Be Used for the Primary Prevention of Cardiovascular Disease in the General Population?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
por: Kim, Ae Jin, et al.
Publicado: (2014)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
por: Diaz, Temistocles, et al.
Publicado: (2020)

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
por: Botton, Jérémie, et al.
Publicado: (2022)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis
por: Stegeman, Inge, et al.
Publicado: (2015)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
por: Xie, Wenchao, et al.
Publicado: (2019)

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach
por: Cofer, Lucas B., et al.
Publicado: (2022)

Trends in the Stroke Death Rate Among Mississippi Adults, 2000–2016
por: Mendy, Vincent L., et al.
Publicado: (2019)

Aspirin thromboprophylaxis in joint replacement surgery
por: Sharda, Anish V., et al.
Publicado: (2022)

Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
por: Djatche, Laurence M., et al.
Publicado: (2018)

Underutilization of Aspirin Persists in US Ambulatory Care for the Secondary and Primary Prevention of Cardiovascular Disease
por: Stafford, Randall S, et al.
Publicado: (2005)

Use of Aspirin for Primary and Secondary Cardiovascular Disease Prevention in the United States, 2011–2012
por: Mainous, Arch G., et al.
Publicado: (2014)

Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis
por: Judge, Conor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nffea1vidbj0i1mrrderu7g286